Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients

OBJECTIVES: Hydroxychloroquine is an antimalarial agent that has been used in systemic lupus erythematosus and rheumatoid arthritis treatment for many years. Recently, novel mechanisms of action have been proposed, thereby broadening the therapeutic perspective of this medication. The purpose of thi...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Juliana Cruz da Silva, Henrique Ataide Mariz, Laurindo Ferreira da Rocha Júnior, Priscilla Stela Santana de Oliveira, Andrea Tavares Dantas, Angela Luzia Branco Pinto Duarte, Ivan da Rocha Pitta, Suely Lins Galdino, Maira Galdino da Rocha Pitta
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier España 2013-06-01
Schriftenreihe:	Clinics
Schlagworte:	Systemic Lupus Erythematosus Rheumatoid Arthritis Th17 cells Hydroxychloroquine
Online-Zugang:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600766
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!